Navigation Links
PharmAthene to Present at Rodman & Renshaw Annual Global Investment Conference
Date:9/3/2013

ANNAPOLIS, Md., Sept. 3, 2013 /PRNewswire/ -- PharmAthene, Inc. (NYSE MKT: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that Eric I. Richman, President and Chief Executive Officer will present at the Rodman & Renshaw Annual Global Investment Conference on Monday, September 9, 2013 at 10:25 a.m. EDT in Room 7.03, 7th Floor of the Millennium Broadway Hotel, New York. Event:Rodman & Renshaw Annual Global Investment ConferenceDate:Monday, September 9, 2013Place:Millennium Broadway Hotel, New York, NYTime:10:25 am EDT About PharmAthenePharmAthene was formed to meet the critical needs of the United States and its allies by developing and commercializing medical countermeasures against biological and chemical threats. PharmAthene's current biodefense portfolio includes the following product candidates:

  • SparVax® - a next generation recombinant protective antigen (rPA) anthrax vaccine
  • Recombinant BChE - a novel bioscavenger for the prevention and treatment of morbidity associated with exposure to chemical nerve agents
  • Valortim® - a fully human monoclonal antibody for the prevention and treatment of anthrax infection
  • In addition, in May 2013, the Delaware Supreme Court issued its ruling on the appeal in our litigation with SIGA Technologies, affirming the Court of Chancery's finding that SIGA was liable for breach of contract, reversing its finding of promissory estoppel, and remanding the case back to the Court of Chancery to reconsider the appropriate remedy and award of attorney's fees and expert witness costs in light of the Supreme Court's opinion. For more information about PharmAthene, please visit www.PharmAthene.com.


    '/>"/>
    SOURCE PharmAthene, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1

    Related medicine technology :

    1. PharmAthene and Theraclone Sciences Announce Merger Agreement to Create Diversified Biologics Company Targeting Government and Commercial Markets
    2. PharmAthene Reports First Quarter 2013 Financial And Operational Results
    3. New Data Show PharmAthenes Recombinant Bioscavenger Binds To A Broad Spectrum Of Chemical Nerve Agents
    4. SIGA Technologies Files Notice of Appeal in PharmAthene Litigation
    5. Inovio Pharmaceuticals to Present at Upcoming Investor Conferences
    6. Amgen And Cytokinetics Announce The First Presentation Of Data From Phase 2 ATOMIC-AHF Study Of Omecamtiv Mecarbil
    7. AcelRx Pharmaceuticals to Present at the Stifel Healthcare Conference 2013
    8. Alexza Pharmaceuticals to Present at the Stifel Healthcare Conference 2013
    9. PTC Therapeutics to Present at Upcoming Investor Conferences
    10. Epizyme, Inc. to Present at Upcoming Conferences in September
    11. Genocea Biosciences Selected To Present Late-Breaking Oral Presentation At ICAAC 2013
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/11/2019)... DIEGO (PRWEB) , ... June 11, 2019 , ... ... global Contract Development and Manufacturing Organization (CDMO) serving the global biopharmaceutical and biotechnology ... of Wei Chen, Ph.D as the company's new Chief Executive Officer (CEO). Dr ...
    (Date:6/6/2019)... ... June 06, 2019 , ... ... announced today that it was selected as the “Best Patient Registration and Scheduling ... top clinical and health administration platforms and products in the healthcare industry. ...
    (Date:6/6/2019)... ... June 05, 2019 , ... The number of neonatal therapists ... earn the designation of Certified Neonatal Therapist (CNT). It highlights specialized professionals who ... the Neonatal Therapy National Certification Board (NTNCB). Today, more than 300 professionals internationally ...
    Breaking Medicine Technology:
    (Date:6/13/2019)... ... June 13, 2019 , ... Many people with back pain that radiates ... term itself is widely misunderstood and so are its treatments, according to Kaliq Chang, ... , “Sciatica is commonly used to describe nerve-like pain traveling down ...
    (Date:6/13/2019)... ... June 13, 2019 , ... The University of Pittsburgh School of ... in Health Informatics (MSHI ) degree program to address the growing need for professionals ... is part of a larger effort for SHRS to bring more graduate degrees online. ...
    (Date:6/13/2019)... NEW YORK (PRWEB) , ... ... ... of 3D printing—including medical and dental implants, additive manufacturing (AM)-enabled tissue fabrication, ... Every day, physicians are using AM medical technologies to improve patient care. ...
    (Date:6/12/2019)... , ... June 12, 2019 , ... ... causing relationships with caregivers and dementia patients to deteriorate. , Researchers from ... included a survey with professional caregivers who care for people who have dementia ...
    (Date:6/12/2019)... ... June 12, 2019 , ... ... quality assurance expert with more than 25 years of experience in quality systems ... all classes of medical devices, has joined NDA Partners as an Expert Consultant. ...
    Breaking Medicine News(10 mins):